Abstract
Background
Approximately 20 % of patients affected by pancreatic ductal adenocarcinoma are amenable to surgical resection. Several tumours are reported as “borderline resectable” because of their proximity to the major vessels. In the effort to achieve a radical tumour removal, vein resection has been proposed, but its oncological benefits remain debated.
Methods
Our aim is to investigate morbidity, mortality and survival after pancreatectomy with vein resection.
Results
Forty patients underwent pancreatectomy and vein resection (group A), and 20 patients (group B) underwent bilio-enteric and/or gastro-entero bypass. In group A, cancer vein invasion was microscopically proven in 14 cases (35 %). Vein infiltration, tumour differentiation and node-positive disease were not adverse prognostic variables. No difference in survival was seen over a 1-year follow-up. After this period, group A showed significant survival benefits with a longer stabilisation of the disease (p = 0.005). Tumour-free resection margins and adjuvant chemoradiotherapy were the most important prognostic factors (p < 0.05).
Conclusions
Suspicion of vein infiltration should not be a contraindication to resection. Pancreatectomy can be safely performed with an acceptable morbidity and better survival trend.
Similar content being viewed by others
References
Gillen S, Schuster T, Meyer Zum Büschenfelde C et al (2010) Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7(4):e1000267
Neoptolemos JP, Dunn JA, Stocken DD et al (2001) European Study Group for Pancreatic Cancer. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358(9293):1576–1585
Malleo G, Marchegiani G, Salvia R et al (2011) Pancreaticoduodenectomy for pancreatic cancer: the Verona experience. Surg Today 41(4):463–470
Massucco P, Capussotti L, Magnino A et al (2006) Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Ann Surg Oncol 13(9):1201–1208
D’Onofrio M, Barbi E, Girelli R et al (2010) Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: an overview. World J Gastroenterol 16(28):3478–3483
Reni M, Cereda S, Balzano G et al (2009) Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma. Cancer Chemother Pharmacol 64(6):1253–1259
Morganti AG, Massaccesi M, La Torre G et al (2010) A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. Ann Surg Oncol 17(1):194–205
Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21:195–200
Neoptolemos JP, Stocken DD, Friess H et al (2004) European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350(12):1200–1210
Katz MH, Lee JE, Pisters PW et al (2012) Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniques. J Am Coll Surg 215(2):e11–e18. doi:10.1016/j.jamcollsurg.2012.05.015
Abrams RA, Lowy AM, O’Reilly EM et al (2009) Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16(7):1751–1756. doi:10.1245/s10434-009-0413-9
Mollberg N, Rahbari NN, Koch M et al (2011) Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 254(6):882–893. doi:10.1097/SLA.0b013e31823ac299, Review
National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Pancreatic adenocarcinoma. http://www.nccn.org/professionals/physician_gls/default.asp. Accessed 27 Feb 2010
Katz MHG, Marsh R, Herman JM, Shi Q, Collison E, Venook AP, Kindler HL, Alberts SR, Philip P, Lowy AM, Pisters PWT, Posner MC, Berlin JD, Ahmad SA (2013) Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol 20:2787–2795
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Bassi C, Dervenis C, Butturini G et al (2005) International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an International Study Group (ISGPF) Definition. Surgery 138(1):8–13, Review
Fuhrman GM, Leach SD, Staley CA et al (1996) Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223:154–162
Boggi U, Del Chiaro M, Croce C et al (2009) Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer. Surgery 146(5):869–881
Lygidakis NJ, Singh G, Bardaxoglou E et al (2004) Mono-bloc total spleno-pancreaticoduodenectomy for pancreatic head carcinoma with portal-mesenteric venous invasion: a prospective randomized study. Hepatogastroenterology 51:427–433
Illuminati G, Carboni F, Lorusso R et al (2008) Results of a pancreatectomy with a limited venous resection for pancreatic cancer. Surg Today 38(6):517–523
Carrère N, Sauvanet A, Goere D et al (2006) Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg 30(8):1526–1535
Martin RC, Scoggins CR, Egnatashvili V et al (2009) Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes. Arch Surg 144(2):154–159
Chakravarty KD, Hsu JT, Liu KH et al (2010) Prognosis and feasibility of en-bloc vascular resection in stage II pancreatic adenocarcinoma. World J Gastroenterol 28(8):997–1002
Müller SA, Hartel M, Mehrabi A et al (2009) Vascular resection in pancreatic cancer surgery: survival determinants. J Gastrointest Surg 13(4):784–792
Zhou GW, Wu WD, Xiao WD et al (2005) Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases. Hepatobiliary Pancreat Dis Int 4(1):130–134
Adham M, Mirza DF, Chapuis F et al (2006) Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors. HPB (Oxford) 8(6):465–473
Ramacciato G, Mercantini P, Petrucciani N et al (2009) Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? Ann Surg Oncol 16(4):817–825, Review
Siriwardana HPP, Siriwardena AK (2006) Systemic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93:662–673
Chua TC, Saxena A (2010) Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg 14:1442–1452
Büchler MW, Werner J, Weitz J (2010) R0 in pancreatic cancer surgery: surgery, pathology, biology, or definition matters? Ann Surg 251(6):1011–1012
White R, Lee C, Anscher M et al (1999) Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 6(1):38–45
Tse RV, Dawson LA, Wei A, Moore M (2008) Neoadjuvant treatment for pancreatic cancer—a review. Crit Rev Oncol Hematol 65(3):263–274
Wanebo HJ, Glicksman AS, Vezeridis MP et al (2000) Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg 135(1):81–87, discussion 88
Lind PA, Isaksson B, Almström M et al (2008) Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma. Acta Oncol 47(3):413–420
Ishikawa O, Ohigashi H, Imaoka S et al (1992) Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 215(3):231–236
Hackert T, Büchler MW (2010) Vascular resections in pancreatic cancer. Updates Surg 62(2):73–74
Acknowledgments
Written informed consent was obtained for publication of clinical data.
Conflicts of interest
The authors declare that they have no competing interests.
Author contributions
FS1, GM2 and CB2 analysed the data and wrote the manuscript. FS1 and CC1 participated in the acquisition and interpretation of statistical data. FS1, DD2, GM2 and CB2 contributed to the final version and carried out the clinical report. DD2, MM2, RS2 and GB2 contributed with technical help and general support. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Selvaggi, F., Mascetta, G., Daskalaki, D. et al. Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study. Langenbecks Arch Surg 399, 659–665 (2014). https://doi.org/10.1007/s00423-014-1194-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-014-1194-6